/term/total-liabilities/XKRX:456570 IMGT (XKRX:456570) Total Liabilities
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Total Liabilities

IMGT (XKRX:456570) Total Liabilities : ₩27,417.18 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Total Liabilities?

IMGT's Total Liabilities for the quarter that ended in Dec. 2023 was ₩27,417.18 Mil.

IMGT's quarterly Total Liabilities declined from Dec. 2021 (₩48,538.45 Mil) to Dec. 2022 (₩42,303.19 Mil) and declined from Dec. 2022 (₩42,303.19 Mil) to Dec. 2023 (₩27,417.18 Mil).

IMGT's annual Total Liabilities declined from Dec. 2021 (₩48,538.45 Mil) to Dec. 2022 (₩42,303.19 Mil) and declined from Dec. 2022 (₩42,303.19 Mil) to Dec. 2023 (₩27,417.18 Mil).


IMGT Total Liabilities Historical Data

The historical data trend for IMGT's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Total Liabilities Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
22,756.17 48,538.45 42,303.19 27,417.18

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Total Liabilities 22,756.17 48,538.45 42,303.19 27,417.18

IMGT Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

IMGT's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26360.544+(68.753+111.466
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+876.413)
=27,417.18

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=10559.766--16857.411
=27,417.18

IMGT's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26360.544+(68.753+111.466
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+876.413)
=27,417.18

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=10559.766--16857.411
=27,417.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Total Liabilities Related Terms

Thank you for viewing the detailed overview of IMGT's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT (XKRX:456570) Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines